Home › Major Depressive Disorder › Arizona › Phoenix
Major Depressive Disorder clinical trials in Phoenix, AZ
8 studies for Major Depressive Disorder are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
RecruitingPhase 3
- NoesisPharma, LLC, Phoenix
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 2
- Clinical Research Site, Phoenix
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
RecruitingPhase 2
- IMA Clinical Research Phoenix, Phoenix
Study of ALTO-300 in MDD
RecruitingPhase 2
- Site 200, Phoenix
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
RecruitingPhase 2
- Draig Clinical Site, Phoenix
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
RecruitingPhase 3
- Vanda Investigational Site, Phoenix
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
RecruitingPhase 2
- NoesisPharma, LLC, Phoenix
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
RecruitingPhase 2
- Ima Clinical Research Phoenix (Alea) /ID# 277516, Phoenix
Major Depressive Disorder trials in other cities
- New York City, NY34 studies
- Boston, MA31 studies
- Atlanta, GA24 studies
- Houston, TX21 studies
- Philadelphia, PA20 studies
- Orlando, FL18 studies
- Miami, FL17 studies
- Tampa, FL17 studies
- Chicago, IL15 studies
- San Diego, CA14 studies
- Orange, CA13 studies
- Las Vegas, NV13 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer24 studies
- Non-Small Cell Lung Cancer21 studies
- Metastatic Cancer19 studies
- Obesity19 studies
- Pancreatic Cancer18 studies
- Cancer (all types)17 studies
- Cardiovascular Disease16 studies
- Prostate Cancer16 studies
- Multiple Myeloma16 studies
- Heart Failure16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.